Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 42 Show results per page	View Search Criteria \| Help With Results


1.		Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				20 and over				Other				ENCITJ-GC01 NCT00503321


2.		Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				20 and over				Other				JACCRO GC-05 NCT00639327

Last Modified: 5/8/2008 First Published: 8/5/2005


3.		Phase III Randomized Study of S-1 and Cisplatin Versus Fluorouracil and Cisplatin in Patients With Unresectable Locally Advanced or Metastatic Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				TAIHO-TPU-S1301 QUINT-TPU-S1301, NCT00400179


4.		Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 80				Other				HKIT-GC NCT00216034


5.		Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 77				Pharmaceutical / Industry				ISO/5FU-10 NCT00195572


6.		A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 75				Other				JCOG0501 C000000279, NCT00252161


7.		Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 79				Other				JACCRO GC-03 NCT00287768

Last Modified: 9/11/2008 First Published: 6/9/2006


8.		Phase III Randomized Study of Adjuvant Chemotherapy Comprising S-1 Versus Tegafur-Uracil (UFT) in Patients With Definitively Treated Stage III or IV Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 75				Other				YCU-BRI-HN-05-01 NCT00336947


9.		Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 and over				Pharmaceutical / Industry				01023017 NCT00498225

Last Modified: 9/15/2008 First Published: 4/15/2008


10.		Phase III Randomized Study of Adjuvant Tegafur-Uracil and Leucovorin Calcium Versus S-1 in Patients With Resected Stage III Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Treatment				Active				20 to 80				Other				TMDU-TRICC0706 TRICC0706, NCT00660894

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute